Ipatimup

RESEARCHDIAGNOSTICSTRANSLATIONOUTREACH

António Polónia

Name: António Polónia

E-mail: apolonia@ipatimup.pt

Extension:

225570700

António Polónia

Member of

Medical Specialist of Ipatimup Diagnostics

Short CV

Surgical Pathologist (MD) at Ipatimup Diagnostics (2014-Present)

Degree in Medicine (MD) (1998-2004): Faculdade de Ciência Médicas da Universidade Nova de Lisboa (FCM-UNL)

Master´s degree in Molecular Oncology (2010-2012): Faculdade de Medicina da Universidade do Porto (FMUP)

PhD degree in Molecular Oncology (2012-2018): Faculdade de Medicina da Universidade do Porto (FMUP)

Invited Associate Professor in Escola de Medicina e Ciências Biomédicas da Universidade Fernando Pessoa (EMCB-UFP) (2023-Present)

Co-chair of the Digital and Computational Pathology Working Group (DCP-WG) of the European Society of Pathology (ESP) (2021-Present)

First Author

1. Polónia A, Canelas C, Caramelo A

The spectrum of HER2 expression in breast cancer: linking immunohistochemistry quantification with in situ hybridization assay. Virchows Archiv : an international journal of pathology 480: 1171-1179, 2022. [Article]

doi: 10.1007/s00428-022-03290-y PMID: 35137279.

4.5 (*)

2. Polónia A, Canelas C, Caramelo A

Reply to letter to the editor by Lee et al. Virchows Archiv : an international journal of pathology 481: 329-330, 2022. [Letter]

doi: 10.1007/s00428-022-03357-w PMID: 35699783.

4.5 (*)

3. Polónia A, Campelos S, Ribeiro A, Aymore I, Pinto D, Biskup-Fruzynska M, Veiga RS, Canas-Marques R, Aresta G, Araújo T, Campilho A, Kwok S, Aguiar P, Eloy C

Artificial Intelligence Improves the Accuracy in Histologic Classification of Breast Lesions. American journal of clinical pathology 155: 527-536, 2021. [Article]

doi: 10.1093/ajcp/aqaa151 PMID: 33118594.

2.5 (*)

4. Polónia A, Caramelo A

HER2 in situ hybridization test in breast cancer: quantifying margins of error and genetic heterogeneity. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34: 1478-1486, 2021. [Article]

doi: 10.1038/s41379-021-00813-x PMID: 33980971.

7.8 (*)

5. Polónia A, Pinto R, Cameselle-Teijeiro JF, Schmitt FC, Paredes J

Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer. Journal of clinical pathology 70: 860-867, 2017. [Article]

doi: 10.1136/jclinpath-2016-203990 PMID: 28373294.

2.9

Senior Author

1. Conde-Sousa E, Vale J, Feng M, Xu K, Wang Y, Della Mea V, La Barbera D, Montahaei E, Baghshah M, Turzynski A, Gildenblat J, Klaiman E, Hong Y, Aresta G, Araújo T, Aguiar P, Eloy C, Polónia A

HEROHE Challenge: Predicting HER2 Status in Breast Cancer from Hematoxylin-Eosin Whole-Slide Imaging. Journal of imaging 8: ., 2022. [Article]

doi: 10.3390/jimaging8080213 PMID: 36005456.

2. Dos Santos J, Cabrebra R, Neves B, Silva E, Polónia A

Squamous cell carcinoma with sarcomatous transformation of the penis. Autopsy & case reports 11: e2021303, 2021. []

doi: 10.4322/acr.2021.303 PMID: 34458171.

3. Machado-Neves R, Teixeira B, Fonseca E, Valente P, Lindoro J, Vila F, Polónia A

Penile Lymphoepithelioma-Like Carcinoma: A Rare Case With PD-L1 Expression. International journal of surgical pathology 29: 690-692, 2021. [Article]

doi: 10.1177/1066896920988340 PMID: 33455515.

1.3 (*)

4. Machado-Neves R, Vale J, Eloy C, Polónia A

HER2 genomic heterogeneity is a frequent event in gastroesophageal adenocarcinoma and correlates with tumor morphology. Pathology, research and practice 216: 153090, 2020. [Article]

doi: 10.1016/j.prp.2020.153090 PMID: 32825958.

2.1 (*)

5. Curado M, Caramelo AS, Eloy C, Polónia A

What to expect from the 2018 ASCO/CAP HER2 guideline in the reflex in situ hybridization test of immunohistochemically equivocal 2+ cases? Virchows Archiv : an international journal of pathology 475: 303-311, 2019. [Article]

doi: 10.1007/s00428-019-02567-z PMID: 30953146.

2.9

@ 2014 Ipatimup Institute of Molecular Pathology and Immunology of the University of Porto